Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

4,6- and 5,7-disubstituted isoquinolines inhibiting PKCz show promise for rheumatoid arthritis

Sep. 10, 2020

Argenx begins first-in-human study of ARGX-117

Sep. 9, 2020

Agrin-culture grows cartilage

Sep. 9, 2020

Lilly begins phase II study of LY-3471851 for SLE

Aug. 28, 2020

UCB studies dapirolizumab pegol in phase III for moderate to severely active SLE

Aug. 28, 2020

Canwell Biotech identifies new TLR7/8 agonists

Aug. 26, 2020

Novartis initiates phase II study of LRX-712 in patients with knee osteoarthritis

Aug. 20, 2020

Targeting the adenosine A2A receptor may prevent osteoarthritis progression

Aug. 19, 2020

FDA issues complete response letter for filgotinib for the treatment of RA

Aug. 19, 2020

UNITY presents 12-week data from phase II study of UBX-0101 in painful osteoarthritis of the knee

Aug. 18, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...